Skip to content

EF Pharma

In bankruptcy Private limited company (pre-2019)founded 2015KBO/BCE: BE 0588.990.037

Information for creditors

Enterprise Court of Brussels · Official Gazette of 19-10-2021
Appeal or third-party opposition 03-11-2021Filing the claim in RegSol 11-11-2021First verification report 17-11-2021Late claim 12-10-2022

Trustee: Thomas Vandendries. The judgment is more than a year old. A claim can no longer be filed, not even late. The trustee knows whether anything will still be paid out.

Lifetime

6 annual accounts with figures on one time axis
peak €6,479 (2015)
-€34,751▲ €3,144
lowest -€101,439 (2016)
-€92,276▼ €69,161
peak €9,357 (2015)
-€283,099▼ €93,205
€769,615▲ 30.8%
peak 0.6 FTE (2020)
0.6 FTE▲ 20.0%
Board1 name since 2018
- 
Documentsfilings and deeds
28-09-202159 days late
2020abbreviated format
Loss of €92,276Staff from 0.5 FTE to 0.6 FTERegistered office moved from Brussels to Sint-Genesius-Rode 12-02Equity from -€189,894 to -€283,099Debts from €588,285 to €769,615Cash from €2,397 to €262

Key points

from the 2020 annual accounts, the last ones filed

Losses

-€294,570 in six years
-3,0432015-101,4392016-46,6292017-28,0692018-23,1152019-92,2762020

Every financial year from 2015 to 2020 closed with a loss. 2016 was the heaviest.

Debts

€769,615 158% of the balance sheet
After one year 45%Within one year 55%

Of this, €426,358 falls due within a year.

Filings

6 annual accounts 6 late
AprilJune31 JulyOctober201620182020

The 2019 accounts came latest: 90 days after the end of the period.

Final months

120 days from reorganisation to bankruptcy
  • 14-06-2021 reorganisation opened
  • 12-10-2021 declared bankrupt
  • 19-10-2021 published in the Official Gazette
No scoreTurnover not published (abbreviated or micro format)

Board and ownership

last known board
FE
Fadoua Echahbouni
Manager, last mentioned in 2020
Board & ownership

Recent changes

110 companies at this address later KOS KONSTRUKT, GICUBUILD, BONDR, ProLineTech, JOHN BUILD, PEQUI RESTAURANT and 104 more · since 2021
Extension of the stay refused Enterprise Court of Brussels · amicable agreement · judgment of 15-09-2021 · Judicial reorganisation
Bankruptcy published Enterprise Court of Brussels · judgment of 12-10-2021 · Bankruptcy
Registered office moved from Sint-Genesius-Rode to Zaventem New registered office: Ikaroslaan 1, 1930 Zaventem · Previous registered office: Waterloose steenweg, 210-1640 Sint-Genesius-Rode · General meeting of 09-08-2021 · Gazette deed
All 17 events

Official details

Source: KBO
Status
In bankruptcydeclared bankrupt on 12-10-2021
Legal form
Private limited company (pre-2019)
Activity
Public relations and communication consultancyNACE 73300
Establishment unit
2.298.550.503since 29-01-2015
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2020

€486,515▲ 22.1%
Filing
Filed on 28-09-2021
Financials

Insights on EF Pharma

Equity fell from €9,357 in 2015 to -€283,099 in 2020, while debts rose from €126,574 to €769,615.

On 14 June 2021 the court opened a judicial reorganisation. 120 days later came the bankruptcy.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about EF Pharma

What is the company number of EF Pharma?
The company number of EF Pharma is 0588.990.037. The VAT number is the same number with BE in front: BE 0588.990.037.
What does EF Pharma do?
According to the KBO register, the main activity is public relations and communication consultancy (NACE 73300).
What is the legal form of EF Pharma?
EF Pharma is a private limited company (pre-2019) (BVBA).
When was EF Pharma founded?
EF Pharma was founded on 29-01-2015.
Is EF Pharma still active?
A bankruptcy is running. A bankruptcy trustee manages the company.Company details
How many employees did EF Pharma have?
EF Pharma had an average of 0.6 full-time equivalents in financial year 2020, according to the filed annual accounts.Financials
What is the turnover of EF Pharma?
The annual accounts for financial year 2020 state no turnover. The abbreviated or micro format does not require it.
Is EF Pharma profitable?
In financial year 2020, EF Pharma made a loss of €92,276.
Where can I find the annual accounts of EF Pharma?
EF Pharma filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2020.

Next steps

Keep this company with today's facts in a case file.